Jiangsu Hengrui Medicine
600276.SS
A$13.64
Share price
2.84%
Change (1 day)
59.94%
Change (1 year)
Categories
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics
Jiangsu Hengrui Medicine (600276.SS) - Cash on Hand
Cash on Hand as of March 2025 : A$5.11 Billion
According to Jiangsu Hengrui Medicine
's latest financial reports the company has A$5.11 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Jiangsu Hengrui Medicine - Cash on Hand chart (from 2000 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | A$4.32 B | 13.67% |
| 2022-12-31 | A$3.80 B | -6.04% |
| 2021-12-31 | A$4.05 B | 23.68% |
| 2020-12-31 | A$3.27 B | 18.16% |
| 2019-12-31 | A$2.77 B | 20.4% |
| 2018-12-31 | A$2.30 B | 174.16% |
| 2017-12-31 | A$0.84 B | -14.39% |
| 2016-12-31 | A$0.98 B | -9.73% |
| 2015-12-31 | A$1.08 B | 59.74% |
| 2014-12-31 | A$0.68 B | 69.38% |
| 2013-12-31 | A$0.40 B | 95.84% |
| 2012-12-31 | A$0.20 B | 39.28% |
| 2011-12-31 | A$0.14 B | -0.56% |
| 2010-12-31 | A$0.14 B | 28.53% |
| 2009-12-31 | A$0.11 B | 19.1% |
| 2008-12-31 | A$96.78 M | -26.84% |
| 2007-12-31 | A$0.13 B | 41.2% |
| 2006-12-31 | A$93.69 M | 28.2% |
| 2005-12-31 | A$73.08 M | 28.62% |
| 2004-12-31 | A$56.81 M | 73.63% |
| 2003-12-31 | A$32.72 M | -20.26% |
| 2002-12-31 | A$41.04 M | -36.03% |
| 2001-12-31 | A$64.15 M | -38.61% |
| 2000-12-31 | A$0.10 B | 478.06% |
| 1999-12-31 | A$18.07 M | 223.03% |
| 1998-12-31 | A$5.59 M | 15.62% |
| 1997-12-31 | A$4.84 M |